Method for obtaining rifapentine with a new crystalline form
AssigneeInterquim S.A. De C.V.
InventorsAaeón RODRIGUEZ WELTON, Diego Armando PÉREZ ROJAS, Blanca Miriam SANTOYO TEPOLE
Life of this patent
Estimating the term…
Loading patent…
AssigneeInterquim S.A. De C.V.
InventorsAaeón RODRIGUEZ WELTON, Diego Armando PÉREZ ROJAS, Blanca Miriam SANTOYO TEPOLE
Estimating the term…
A new crystalline form of rifapentine, the characterization thereof and a method for obtaining same is disclosed. The method for obtaining the new crystalline form includes the steps of adding a mixture of dimethylformamide, tert-butylamine and paraformaldehyde to rifamycin S in the presence of glacial acetic acid; adding paraformaldehyde and heating; subsequently adding 1-amino-4-cyclopentylpiperazine to dimethylformamide; adding ascorbic acid to water; and mixing, filtering and washing the product The yield of raw rifapentine is 87+5% with 99.00% purity.
A pure crystalline form of rifapentine having an X-ray powder diffraction pattern with the values shown in Table 1.
The pure crystalline form of rifapentine having the X-ray powder diffractogram according to FIG. 1.
A process for the preparation of the pure crystalline form of rifapentine comprising:
Dependencies are inferred from the claim text.